SCHEMBL3060108

SCHEMBL3060108

COc1ccc(S(=O)(=O)N2CCc3cc(OCc4ccccc4)c(OC)cc3C2=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 2/20 0.50
GPR84 Q9NQS5 1/20 0.49
PKM P14618 2/20 0.48
MMP1 P03956 1/20 0.48
MMP2 P08253 1/20 0.48
MMP7 P09237 1/20 0.48
MMP9 P14780 1/20 0.48
MMP12 P39900 1/20 0.48
MMP14 P50281 1/20 0.48
MMP15 P51511 1/20 0.48
MMP16 P51512 1/20 0.48
MMP26 Q9NRE1 1/20 0.48
REV1 Q9UBZ9 1/20 0.46
PDE4A P27815 1/20 0.45
PDE4B Q07343 1/20 0.45
PDE4C Q08493 1/20 0.45
PDE4D Q08499 1/20 0.45
HTR2A P28223 2/20 0.45
HTR2C P28335 2/20 0.45
HTR2B P41595 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3051148 0.91 CHRNA7 (0.48) CHRNA7GPR84REV1PDE4APDE4B
SCHEMBL3054657 0.86 CHRNA7 (0.52) CHRNA7GPR84REV1PDE4BHTR2A
SCHEMBL3042255 0.86 CHRNA7 (0.48) CHRNA7GPR84REV1PDE4APDE4B
SCHEMBL3059281 0.84 CHRNA7 (0.46) CHRNA7GPR84PDE4APDE4BPDE4C
SCHEMBL3064135 0.83 REV1 (0.56) CHRNA7GPR84REV1HTR2AHTR2C
SCHEMBL3046225 0.80 MMP2 (0.54) PKMMMP1MMP2MMP7MMP9
SCHEMBL3051832 0.79 CHRNA7 (0.53) CHRNA7GPR84REV1HTR2AHTR2C
SCHEMBL3051091 0.79 CA2 (0.54) CHRNA7GPR84REV1HTR2AHTR2C
SCHEMBL13178635 0.78 CYP11B1 (0.48) GPR84PKMPDE4APDE4BPDE4C
SCHEMBL3051781 0.78 PKM (0.48) PKMMMP1MMP2MMP7MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US claimed
US-8394825-B2 Compound STERIX LIMITED (GB) 2013-03-12 US disclosed
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US disclosed
EP-2155192-A2 TETRAHYDROISOQUINOLINES AS TUMOUR GROWTH INHIBITORS Sterix Limited (GB) 2010-02-24 EP disclosed
WO-2008117061-A2 TETRAHYDROISOQUINOLINES AS TUMOUR GROWTH INHIBITORS STERIX LIMITED (GB) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222299-A1 COMPOUND MKI67, VHL, MYC CHRNA7 4760/4885GPR84 2185/4885PKM 3021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.